A biotech company based out of Massachusetts found a tremendous amount of success mid-week after the company announced that the pivotal Phase 3 PIVOT-PO trial evaluating tebipenem...

To read the full story on AllPennyStocks.com, click here.

Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Jun 2025 to Jul 2025 Click Here for more Spero Therapeutics Charts.
Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Jul 2024 to Jul 2025 Click Here for more Spero Therapeutics Charts.